

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.33904094 |
| 2 | response to peptidoglycan (GO:0032494) | 4.59525898 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 4.50096740 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.28320638 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 4.23844176 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 3.97568963 |
| 7 | T-helper 1 type immune response (GO:0042088) | 3.81181983 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.74424066 |
| 9 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.72098462 |
| 10 | positive regulation of heat generation (GO:0031652) | 3.70411948 |
| 11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.68344102 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.66734339 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63163834 |
| 14 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.57082646 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.51049466 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.51049466 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.51049466 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.51049466 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.51049466 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.51049466 |
| 21 | glycosphingolipid catabolic process (GO:0046479) | 3.49162642 |
| 22 | oligosaccharide catabolic process (GO:0009313) | 3.41029485 |
| 23 | amino sugar catabolic process (GO:0046348) | 3.37539478 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.33676309 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33323493 |
| 26 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.33121220 |
| 27 | regulation of chemokine biosynthetic process (GO:0045073) | 3.31940221 |
| 28 | granulocyte activation (GO:0036230) | 3.31167815 |
| 29 | regulation of fever generation (GO:0031620) | 3.30219825 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.27305689 |
| 31 | virion attachment to host cell (GO:0019062) | 3.25962152 |
| 32 | adhesion of symbiont to host cell (GO:0044650) | 3.25962152 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22898925 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.22791248 |
| 35 | cellular response to type I interferon (GO:0071357) | 3.22791248 |
| 36 | response to type I interferon (GO:0034340) | 3.20486036 |
| 37 | N-acetylneuraminate metabolic process (GO:0006054) | 3.20265653 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19487594 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.18970503 |
| 40 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.18927404 |
| 41 | regulation of macrophage chemotaxis (GO:0010758) | 3.15469133 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14981083 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.14981083 |
| 44 | monocyte chemotaxis (GO:0002548) | 3.14474850 |
| 45 | germinal center formation (GO:0002467) | 3.14130300 |
| 46 | myeloid dendritic cell differentiation (GO:0043011) | 3.13888020 |
| 47 | regulation of podosome assembly (GO:0071801) | 3.13546692 |
| 48 | glycolipid catabolic process (GO:0019377) | 3.13517441 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 3.10626228 |
| 50 | macrophage activation (GO:0042116) | 3.10332923 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09409532 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08911043 |
| 53 | low-density lipoprotein particle clearance (GO:0034383) | 3.08892702 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08278548 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.04072253 |
| 56 | defense response to protozoan (GO:0042832) | 3.03771998 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 3.02592579 |
| 58 | detection of other organism (GO:0098543) | 3.01243838 |
| 59 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00366433 |
| 60 | response to protozoan (GO:0001562) | 2.99660557 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 2.98385744 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.97197772 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 2.97197772 |
| 64 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95026102 |
| 65 | detection of external biotic stimulus (GO:0098581) | 2.94325253 |
| 66 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.93688277 |
| 67 | regulation of heat generation (GO:0031650) | 2.92684093 |
| 68 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90793913 |
| 69 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.89864643 |
| 70 | regulation of interleukin-12 production (GO:0032655) | 2.89388290 |
| 71 | neutrophil activation (GO:0042119) | 2.88132727 |
| 72 | ceramide catabolic process (GO:0046514) | 2.87002993 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 2.86302811 |
| 74 | regulation of cholesterol storage (GO:0010885) | 2.85304326 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84793492 |
| 76 | microglial cell activation (GO:0001774) | 2.84441584 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.83261710 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.83115558 |
| 79 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.82132349 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 2.81422763 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80064074 |
| 82 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.79913034 |
| 83 | detection of bacterium (GO:0016045) | 2.79880981 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78465729 |
| 85 | adhesion of symbiont to host (GO:0044406) | 2.78269111 |
| 86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76053609 |
| 87 | B cell mediated immunity (GO:0019724) | 2.75614273 |
| 88 | cellular response to lipopolysaccharide (GO:0071222) | 2.75141495 |
| 89 | positive regulation of interferon-alpha production (GO:0032727) | 2.74149558 |
| 90 | regulation of mast cell activation (GO:0033003) | 2.73125690 |
| 91 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.70926779 |
| 92 | cellular response to molecule of bacterial origin (GO:0071219) | 2.70609041 |
| 93 | cellular response to interferon-gamma (GO:0071346) | 2.68823137 |
| 94 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.67147393 |
| 95 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66591317 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66189799 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 2.64778066 |
| 98 | positive regulation of type 2 immune response (GO:0002830) | 2.64556089 |
| 99 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64234441 |
| 100 | positive regulation of acute inflammatory response (GO:0002675) | 2.63933683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.05220592 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.25908937 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.43002200 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.76570436 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40193624 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38255682 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.20559803 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.11837844 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83774802 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.70527792 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61111587 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57561866 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52492450 |
| 14 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.38691231 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20237301 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15349654 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12769123 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09367787 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07785224 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04911483 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00087782 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76407579 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75637568 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75469323 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71004335 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69850120 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68112505 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67683334 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66452851 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66452128 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66019102 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61820366 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60668329 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60094886 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58608665 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53887156 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49664178 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47476094 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47463850 |
| 40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47012727 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43414984 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35266860 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32271884 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30883284 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29904189 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28522468 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28420336 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27429827 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27181342 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26661734 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25785007 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25145771 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24899941 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24323623 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24091699 |
| 56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22895553 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22381598 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22189443 |
| 59 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21055313 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20302726 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20093534 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17039836 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16819795 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15288769 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14676497 |
| 66 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11833047 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11209658 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11117790 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.09929110 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09847196 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08519375 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04388790 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.01368860 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00833308 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97769970 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97684490 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96165069 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95855639 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92947413 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90062030 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87374363 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85586715 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85528369 |
| 84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84622947 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83439968 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82111819 |
| 87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82041576 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81276149 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.80847861 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.80468362 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78794164 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.78286400 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77425449 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77100686 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76311385 |
| 96 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75429119 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 0.75162961 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74827812 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73786849 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.73590812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.80118658 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.02250983 |
| 3 | MP0003724_increased_susceptibility_to | 3.79283747 |
| 4 | MP0006082_CNS_inflammation | 3.53208026 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.23857377 |
| 6 | MP0003436_decreased_susceptibility_to | 3.21960238 |
| 7 | MP0009785_altered_susceptibility_to | 3.10612735 |
| 8 | MP0009840_abnormal_foam_cell | 2.96299348 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.80111540 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.70473449 |
| 11 | MP0002419_abnormal_innate_immunity | 2.69480034 |
| 12 | MP0004510_myositis | 2.60009833 |
| 13 | MP0001790_abnormal_immune_system | 2.59726665 |
| 14 | MP0005387_immune_system_phenotype | 2.59726665 |
| 15 | MP0005671_abnormal_response_to | 2.58808445 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.49529168 |
| 17 | MP0005025_abnormal_response_to | 2.46418136 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.39431366 |
| 19 | MP0009764_decreased_sensitivity_to | 2.38621779 |
| 20 | MP0000343_altered_response_to | 2.30842265 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.22480471 |
| 22 | MP0003075_altered_response_to | 2.21839241 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.09137671 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.06402568 |
| 25 | MP0002723_abnormal_immune_serum | 2.03261507 |
| 26 | MP0001800_abnormal_humoral_immune | 1.97613904 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.95937914 |
| 28 | MP0000685_abnormal_immune_system | 1.94211456 |
| 29 | MP0000604_amyloidosis | 1.93591541 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.73957238 |
| 31 | MP0002254_reproductive_system_inflammat | 1.71934053 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.70530605 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.69279396 |
| 34 | MP0001819_abnormal_immune_cell | 1.69208555 |
| 35 | MP0003690_abnormal_glial_cell | 1.67593606 |
| 36 | MP0008004_abnormal_stomach_pH | 1.66684217 |
| 37 | MP0008469_abnormal_protein_level | 1.66485084 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.64941079 |
| 39 | MP0002405_respiratory_system_inflammati | 1.59612446 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.55315357 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.54187331 |
| 42 | MP0009278_abnormal_bone_marrow | 1.53174539 |
| 43 | MP0005310_abnormal_salivary_gland | 1.48624661 |
| 44 | MP0004947_skin_inflammation | 1.46329732 |
| 45 | MP0006054_spinal_hemorrhage | 1.43617628 |
| 46 | MP0005451_abnormal_body_composition | 1.42464675 |
| 47 | MP0001853_heart_inflammation | 1.41837500 |
| 48 | MP0003195_calcinosis | 1.41547465 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.39688928 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.39688928 |
| 51 | MP0003448_altered_tumor_morphology | 1.34016443 |
| 52 | MP0005166_decreased_susceptibility_to | 1.25395731 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.18374297 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.18134184 |
| 55 | MP0005365_abnormal_bile_salt | 1.16358671 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.16102566 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.14496231 |
| 58 | MP0000716_abnormal_immune_system | 1.14453730 |
| 59 | MP0000858_altered_metastatic_potential | 1.12681978 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.10149446 |
| 61 | MP0003828_pulmonary_edema | 1.10032765 |
| 62 | MP0005164_abnormal_response_to | 1.05276782 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.00211728 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 0.98521311 |
| 65 | MP0001663_abnormal_digestive_system | 0.95704315 |
| 66 | MP0009763_increased_sensitivity_to | 0.94449485 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.94069814 |
| 68 | MP0000920_abnormal_myelination | 0.92414140 |
| 69 | MP0003646_muscle_fatigue | 0.92003230 |
| 70 | MP0001542_abnormal_bone_strength | 0.91729035 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.90610671 |
| 72 | MP0005535_abnormal_body_temperature | 0.87136927 |
| 73 | MP0005390_skeleton_phenotype | 0.86752363 |
| 74 | MP0000689_abnormal_spleen_morphology | 0.85172696 |
| 75 | MP0005165_increased_susceptibility_to | 0.85033422 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.84768168 |
| 77 | MP0002933_joint_inflammation | 0.84160715 |
| 78 | MP0002398_abnormal_bone_marrow | 0.83022955 |
| 79 | MP0002429_abnormal_blood_cell | 0.81665774 |
| 80 | MP0004883_abnormal_blood_vessel | 0.77584203 |
| 81 | MP0003329_amyloid_beta_deposits | 0.75661578 |
| 82 | MP0005647_abnormal_sex_gland | 0.74679782 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.73775525 |
| 84 | MP0000249_abnormal_blood_vessel | 0.73529005 |
| 85 | MP0003879_abnormal_hair_cell | 0.70705311 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.70554546 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.69821757 |
| 88 | MP0002722_abnormal_immune_system | 0.68849042 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.67683197 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.66685271 |
| 91 | MP0008874_decreased_physiological_sensi | 0.66358162 |
| 92 | MP0000609_abnormal_liver_physiology | 0.66204085 |
| 93 | MP0003186_abnormal_redox_activity | 0.65567150 |
| 94 | MP0001764_abnormal_homeostasis | 0.64660416 |
| 95 | MP0005334_abnormal_fat_pad | 0.63158499 |
| 96 | MP0009115_abnormal_fat_cell | 0.63064324 |
| 97 | MP0003795_abnormal_bone_structure | 0.62661498 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61414474 |
| 99 | MP0001873_stomach_inflammation | 0.60263718 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.60053632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.34916260 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.34916260 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.34916260 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 6.24227124 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.32617271 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.20092472 |
| 7 | Disinhibition (HP:0000734) | 4.84325907 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.67379649 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.66291539 |
| 10 | Mutism (HP:0002300) | 4.36771385 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.36630107 |
| 12 | Loss of speech (HP:0002371) | 4.32208711 |
| 13 | Orchitis (HP:0100796) | 4.18581235 |
| 14 | Glomerulonephritis (HP:0000099) | 4.14616558 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.04893717 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.04063735 |
| 17 | Optic neuritis (HP:0100653) | 4.04063735 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.01484985 |
| 19 | Myositis (HP:0100614) | 3.93154701 |
| 20 | Stomatitis (HP:0010280) | 3.91593077 |
| 21 | Complement deficiency (HP:0004431) | 3.90138342 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.76491378 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.74095432 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.74095432 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.74095432 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61439774 |
| 27 | Nuclear cataract (HP:0100018) | 3.44895900 |
| 28 | Mucopolysacchariduria (HP:0008155) | 3.41448063 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.41448063 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.40467673 |
| 31 | Axonal loss (HP:0003447) | 3.25161256 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.17980820 |
| 33 | Hematochezia (HP:0002573) | 3.14786056 |
| 34 | Abnormality of complement system (HP:0005339) | 3.12585107 |
| 35 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.10438905 |
| 36 | Neurofibrillary tangles (HP:0002185) | 3.00937983 |
| 37 | Inappropriate behavior (HP:0000719) | 2.95991289 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.94985028 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.94056128 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.91887443 |
| 41 | Purpura (HP:0000979) | 2.79038441 |
| 42 | Increased serum ferritin (HP:0003281) | 2.78020433 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.76901109 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.75732647 |
| 45 | Amyloidosis (HP:0011034) | 2.73742234 |
| 46 | Agnosia (HP:0010524) | 2.68721236 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.61766057 |
| 48 | Obstructive lung disease (HP:0006536) | 2.56953122 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56953122 |
| 50 | Hemoptysis (HP:0002105) | 2.54739964 |
| 51 | Diminished motivation (HP:0000745) | 2.51497713 |
| 52 | Apathy (HP:0000741) | 2.51420554 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44429142 |
| 54 | Abnormality of iron homeostasis (HP:0011031) | 2.42143119 |
| 55 | Vasculitis (HP:0002633) | 2.40273954 |
| 56 | Progressive neurologic deterioration (HP:0002344) | 2.34344218 |
| 57 | Nephritis (HP:0000123) | 2.32766247 |
| 58 | Recurrent skin infections (HP:0001581) | 2.32045368 |
| 59 | Polyneuropathy (HP:0001271) | 2.30551597 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.26204108 |
| 61 | Basal ganglia calcification (HP:0002135) | 2.23849954 |
| 62 | Petechiae (HP:0000967) | 2.22986533 |
| 63 | Gingivitis (HP:0000230) | 2.20829199 |
| 64 | Myocardial infarction (HP:0001658) | 2.19742104 |
| 65 | Gangrene (HP:0100758) | 2.18282078 |
| 66 | Meningitis (HP:0001287) | 2.14755418 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.14515713 |
| 68 | Retinal atrophy (HP:0001105) | 2.14451411 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.10754108 |
| 70 | Nausea (HP:0002018) | 2.09261332 |
| 71 | Upper motor neuron abnormality (HP:0002127) | 2.09040547 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08014699 |
| 73 | Pulmonary embolism (HP:0002204) | 2.07544143 |
| 74 | Prolonged neonatal jaundice (HP:0006579) | 2.06581890 |
| 75 | Dementia (HP:0000726) | 2.05732311 |
| 76 | Personality changes (HP:0000751) | 2.04357075 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.03460164 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.02290888 |
| 79 | Encephalitis (HP:0002383) | 2.00721164 |
| 80 | Memory impairment (HP:0002354) | 1.97703563 |
| 81 | Metaphyseal irregularity (HP:0003025) | 1.96048437 |
| 82 | Malnutrition (HP:0004395) | 1.94750655 |
| 83 | Pathologic fracture (HP:0002756) | 1.92072968 |
| 84 | Peripheral demyelination (HP:0011096) | 1.91680939 |
| 85 | Global brain atrophy (HP:0002283) | 1.88518365 |
| 86 | Increased IgM level (HP:0003496) | 1.88065795 |
| 87 | Urticaria (HP:0001025) | 1.87863866 |
| 88 | Abnormality of the pleura (HP:0002103) | 1.87228652 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 1.84217963 |
| 90 | Vertigo (HP:0002321) | 1.84124955 |
| 91 | Acne (HP:0001061) | 1.77647512 |
| 92 | Anorexia (HP:0002039) | 1.75733525 |
| 93 | Arterial thrombosis (HP:0004420) | 1.74378995 |
| 94 | Abnormality of the pericardium (HP:0001697) | 1.73818126 |
| 95 | Increased CSF protein (HP:0002922) | 1.73607645 |
| 96 | Acrocyanosis (HP:0001063) | 1.73459199 |
| 97 | Mesangial abnormality (HP:0001966) | 1.72352553 |
| 98 | Restrictive lung disease (HP:0002091) | 1.71372235 |
| 99 | Recurrent viral infections (HP:0004429) | 1.71286738 |
| 100 | Leukocytosis (HP:0001974) | 1.70879326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.92552608 |
| 2 | BLK | 3.34462929 |
| 3 | GRK7 | 3.09466286 |
| 4 | MAP3K14 | 2.75773840 |
| 5 | TGFBR2 | 2.70503578 |
| 6 | NME2 | 2.69499472 |
| 7 | DDR2 | 2.65938258 |
| 8 | RIPK4 | 2.56287367 |
| 9 | TBK1 | 2.52725551 |
| 10 | ERN1 | 2.35989844 |
| 11 | MAP3K11 | 2.33530196 |
| 12 | IRAK4 | 2.32358578 |
| 13 | MAP4K1 | 2.26041381 |
| 14 | TYK2 | 2.25417388 |
| 15 | MATK | 2.24845360 |
| 16 | TAOK1 | 2.22580881 |
| 17 | TAOK2 | 2.20047965 |
| 18 | ACVR1B | 2.16337046 |
| 19 | CSK | 2.05539792 |
| 20 | FGR | 2.03312310 |
| 21 | IKBKB | 2.02731882 |
| 22 | TXK | 1.99560733 |
| 23 | ADRBK2 | 1.95088291 |
| 24 | MAP3K3 | 1.80440888 |
| 25 | IKBKE | 1.71536877 |
| 26 | RIPK1 | 1.67117371 |
| 27 | MAP2K3 | 1.64410023 |
| 28 | CDC42BPA | 1.48902029 |
| 29 | CAMKK2 | 1.42022888 |
| 30 | JAK3 | 1.37138496 |
| 31 | ZAP70 | 1.32365678 |
| 32 | PIM2 | 1.32322900 |
| 33 | ABL2 | 1.31726409 |
| 34 | MAP3K13 | 1.26989214 |
| 35 | MOS | 1.26506951 |
| 36 | CSF1R | 1.26370344 |
| 37 | SYK | 1.24495809 |
| 38 | PRPF4B | 1.21123444 |
| 39 | LYN | 1.21036645 |
| 40 | FES | 1.13238794 |
| 41 | CHUK | 1.12172750 |
| 42 | IRAK1 | 1.06397974 |
| 43 | DAPK2 | 1.04114596 |
| 44 | MAP3K1 | 1.03231310 |
| 45 | MARK3 | 1.02661410 |
| 46 | TNK2 | 1.01938767 |
| 47 | KIT | 0.97992024 |
| 48 | JAK2 | 0.97879793 |
| 49 | MAP2K6 | 0.97650368 |
| 50 | CAMK1D | 0.97309721 |
| 51 | BMPR2 | 0.96267196 |
| 52 | IRAK2 | 0.93099082 |
| 53 | TAOK3 | 0.88561950 |
| 54 | JAK1 | 0.85433668 |
| 55 | MAP3K5 | 0.83407430 |
| 56 | HCK | 0.82331159 |
| 57 | LCK | 0.82081437 |
| 58 | BTK | 0.76575648 |
| 59 | SIK3 | 0.75675087 |
| 60 | TGFBR1 | 0.72673840 |
| 61 | SIK2 | 0.62589027 |
| 62 | EPHA3 | 0.58964500 |
| 63 | PRKAA2 | 0.56574239 |
| 64 | MAPK4 | 0.51913143 |
| 65 | TYRO3 | 0.49685400 |
| 66 | TESK2 | 0.47856595 |
| 67 | EPHB2 | 0.47367932 |
| 68 | ABL1 | 0.46172175 |
| 69 | PIM1 | 0.46122180 |
| 70 | MAPK7 | 0.44035083 |
| 71 | CDK6 | 0.43651478 |
| 72 | PKN1 | 0.41041764 |
| 73 | PDPK1 | 0.40543567 |
| 74 | RPS6KA6 | 0.39751622 |
| 75 | RPS6KC1 | 0.39506198 |
| 76 | RPS6KL1 | 0.39506198 |
| 77 | EPHB1 | 0.39466461 |
| 78 | MARK2 | 0.37832626 |
| 79 | DYRK3 | 0.37363286 |
| 80 | PDK1 | 0.37075777 |
| 81 | ITK | 0.35230600 |
| 82 | MAPK12 | 0.34453824 |
| 83 | PRKG2 | 0.34351130 |
| 84 | HIPK2 | 0.33981977 |
| 85 | TESK1 | 0.32320859 |
| 86 | STK10 | 0.30428354 |
| 87 | FRK | 0.29721070 |
| 88 | TEC | 0.28551196 |
| 89 | CAMK1G | 0.28156133 |
| 90 | NEK9 | 0.26538206 |
| 91 | FYN | 0.24410955 |
| 92 | SIK1 | 0.24334327 |
| 93 | INSR | 0.24265904 |
| 94 | PRKD2 | 0.23917551 |
| 95 | PRKCD | 0.22155331 |
| 96 | RPS6KA2 | 0.21413342 |
| 97 | PRKACG | 0.21388760 |
| 98 | MAP3K6 | 0.21363146 |
| 99 | PRKCQ | 0.21313733 |
| 100 | DYRK1B | 0.21123280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.66847739 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.49063037 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.91498420 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.86667479 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.72300556 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.66197912 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64243843 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55651054 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43365081 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40971747 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28368129 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25383183 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.18664921 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.15782751 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14375452 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.12840143 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10154893 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07586283 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.06929163 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94008099 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85974357 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73372898 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.62143768 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59774650 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59708772 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59504961 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.59040231 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53817316 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45995075 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44105937 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.43201355 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40034073 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33169983 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.31068727 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29729855 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.24044657 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17808299 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16387098 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15552306 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14804158 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01639042 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01507346 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00133388 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96140551 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93351181 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.91166355 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.88161791 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86538005 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84007100 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81227195 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80575422 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77989739 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76580540 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76303413 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.75888038 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74532288 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.72017605 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71357117 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.65878376 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65229177 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64253686 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62093468 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59798698 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.58995046 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.57871103 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55210970 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50627183 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48078678 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47307988 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45898715 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44480984 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44035840 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.43620175 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42396031 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41303388 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39090924 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38591594 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36546256 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35307877 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32686239 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32445232 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26463408 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.26190078 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25330940 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25024022 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23300398 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.22458785 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21889188 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.21251080 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21175265 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18193271 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17695570 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16076899 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.15429528 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14955731 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14045727 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13823564 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.13050079 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12582477 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12250371 |

